The global aHUS registry: methodology and initial patient characteristics
Atypical hemolytic uremic syndrome (aHUS) is a rare, genetically-mediated systemic disease most often caused by chronic, uncontrolled complement activation that leads to systemic thrombotic microangiopathy (TMA) and renal and other end-organ damage.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
10 December 2015
|
| In: |
BMC nephrology
Year: 2015, Jahrgang: 16, Pages: 1-8 |
| ISSN: | 1471-2369 |
| DOI: | 10.1186/s12882-015-0195-1 |
| Online-Zugang: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12882-015-0195-1 Verlag, lizenzpflichtig, Volltext: https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-015-0195-1 |
| Verfasserangaben: | Christoph Licht, Gianluigi Ardissino, Gema Ariceta, David Cohen, J. Alexander Cole, Christoph Gasteyger, Larry A. Greenbaum, Sally Johnson, Masayo Ogawa, Franz Schaefer, Johan Vande Walle and Véronique Frémeaux-Bacchi |
Search Result 1
The global aHUS registry: methodology and initial patient characteristics
BioMed Central 2015
Article (Journal)
Book/Monograph
Online Resource